Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Argus Health
Fuji
Healthtrust
Johnson and Johnson
US Department of Justice
Cipla
Farmers Insurance
McKinsey

Generated: October 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 002245

« Back to Dashboard

NDA 002245 describes PROLOID, which is a drug marketed by Parke Davis and is included in one NDA. Additional details are available on the PROLOID profile page.

The generic ingredient in PROLOID is thyroglobulin. There is one drug master file entry for this compound. Additional details are available on the thyroglobulin profile page.
Summary for 002245
Tradename:PROLOID
Applicant:Parke Davis
Ingredient:thyroglobulin
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength65MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength325MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 005

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength32MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Fuji
Accenture
Deloitte
Moodys
Chubb
Boehringer Ingelheim
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.